Promoter hypermethylation-mediated downregulation of SNORD113-1 was shown in HCC and SNORD113-1 inhibited in vivo xenografts of HepG2 cells which was associated with inhibition of MAPK/ERK and TGF-β signaling [125]. The gene discussed is MAPK1; the disease is hepatocellular carcinoma.